VALICERT INC
10-Q, EX-27.1, 2000-09-11
COMPUTER PROGRAMMING SERVICES
Previous: VALICERT INC, 10-Q, 2000-09-11
Next: KERYX BIOPHARMACEUTICALS INC, 10-Q, 2000-09-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             APR-01-2000             JAN-01-2000
<PERIOD-END>                               JUN-30-2000             JUN-30-2000
<CASH>                                           5,893                   5,893
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    3,477                   3,477
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                10,613                  10,613
<PP&E>                                           5,016                   5,016
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                  29,459                  29,459
<CURRENT-LIABILITIES>                            7,284                   7,284
<BONDS>                                              0                       0
                                0                       0
                                     34,337                  34,337
<COMMON>                                        26,001                  26,001
<OTHER-SE>                                     (40,987)                (40,987)
<TOTAL-LIABILITY-AND-EQUITY>                    29,459                  29,459
<SALES>                                          2,518                   4,394
<TOTAL-REVENUES>                                 2,518                   4,394
<CGS>                                            1,564                   2,758
<TOTAL-COSTS>                                    1,564                   2,758
<OTHER-EXPENSES>                                 8,022                  14,290
<LOSS-PROVISION>                                (7,068)                (12,654)
<INTEREST-EXPENSE>                                 (12)                    116
<INCOME-PRETAX>                                      0                       0
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    (7,080)                (12,538)
<EPS-BASIC>                                      (2.69)                  (5.02)
<EPS-DILUTED>                                        0                       0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission